Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer

Clinical Trial Details

Golden Biotech GHPanc-1-001

Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Pancreatic Cancer
Study Type: Interventional
Phase: I
Study Start Date: 06/21/18
Study Completion Date: 08/2020

A Phase I/II study to determine the maximum tolerated dose (MTD) and to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of antroquinonol in combination with nab-paclitaxel and gemcitabine in first line metastatic pancreatic cancer.

NCT Number
NCT03310632
Principal Investigator(s)
John Wallmark, MD
Sponsor(s)
Golden Biotechnology Corporation
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female

Location

  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.